<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02221141</url>
  </required_header>
  <id_info>
    <org_study_id>Fabry Disease Cardioscreening</org_study_id>
    <nct_id>NCT02221141</nct_id>
  </id_info>
  <brief_title>Screening of Fabry Disease in Patients With Left Ventricular Hypertrophy Detected in Echocardiography</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Laurence Gabriel</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire Dinant Godinne - UCL Namur</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the prevalence in Belgium of Fabry disease in&#xD;
      patients with unexplained hypertrophic cardiomyopathy measured by echocardiography and to&#xD;
      determine in Fabry patients which was the most frequently initial symptom.&#xD;
&#xD;
      Actually the early diagnosis is important because a treatment exists that can prevent future&#xD;
      complications.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2013</start_date>
  <completion_date type="Anticipated">December 2022</completion_date>
  <primary_completion_date type="Anticipated">December 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of patients with left ventricular hypertrophy who have Fabry Disease mutation</measure>
    <time_frame>1 day</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Left Ventricular Hypertrophy</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with left ventricular hypertrophy&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  unexplained left ventricular hypertrophy&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  isolated septal hypertrophy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Laurence Gabriel</last_name>
    <phone>+32 81 42 21 11</phone>
    <phone_ext>3623</phone_ext>
    <email>laurence.gabriel@uclouvain.be</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Karine Jourdan</last_name>
    <phone>+32 81 42 21 11</phone>
    <phone_ext>3610</phone_ext>
    <email>karine.jourdan@uclouvain.be</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CHU Dinant-Godinne</name>
      <address>
        <city>Yvoir</city>
        <zip>5530</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Laurence Gabriel</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>August 18, 2014</study_first_submitted>
  <study_first_submitted_qc>August 19, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 20, 2014</study_first_posted>
  <last_update_submitted>February 2, 2021</last_update_submitted>
  <last_update_submitted_qc>February 2, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 3, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Centre Hospitalier Universitaire Dinant Godinne - UCL Namur</investigator_affiliation>
    <investigator_full_name>Laurence Gabriel</investigator_full_name>
    <investigator_title>Dr Laurence GABRIEL</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertrophy, Left Ventricular</mesh_term>
    <mesh_term>Hypertrophy</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

